Hutham Olayan - Morgan Stanley Independent Director
| MS Stock | USD 133.66 1.03 0.76% |
Director
Ms. Hutham S. Olayan is Independent Director of Morgan Stanley. Ms. Olayan is Vice Chair since 2018 and principal and director since 1981 of The Olayan Group, a private multinational enterprise that is a diversified global investor and operator of commercial and industrial businesses in Saudi Arabia. Served as President and CEO of The Olayan Groups U.S. operations for almost 30 years until December 2017, overseeing all investment activities in the Americas. Member of the Executive Advisory Board of General Atlantic and a former director of Thermo Electron Corporation since 2006.
| Age | 65 |
| Tenure | 18 years |
| Address | 1585 Broadway, New York, NY, United States, 10036 |
| Phone | 212 761 4000 |
| Web | https://www.morganstanley.com |
Morgan Stanley Management Efficiency
At this time, Morgan Stanley's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop 0.02 in 2024. At this time, Morgan Stanley's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 719.5 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 22.6 B in 2024. Morgan Stanley's management efficiency ratios could be used to measure how well Morgan Stanley manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Lundgren | Visa Class A | 69 | |
| Ruth Porat | Blackstone Group | 62 | |
| Peter Clare | Carlyle Group | 59 | |
| Nella Domenici | AllianceBernstein Holding LP | 60 | |
| Valerie Mosley | Dynex Capital | 59 | |
| Jirong Lyu | Distoken Acquisition | 41 | |
| Jeffrey Hurd | AllianceBernstein Holding LP | 54 | |
| Frederic Salerno | Associated Capital Group | 77 | |
| Kristi Matus | AllianceBernstein Holding LP | 53 | |
| Marc Gabelli | Associated Capital Group | 56 | |
| Rochelle Lazarus | Blackstone Group | 72 | |
| Kelly Ayotte | Blackstone Group | 51 | |
| Jonathan Gray | Blackstone Group | 50 | |
| David Stevens | Dynex Capital | 64 | |
| Bruce Lisman | Associated Capital Group | 74 | |
| Reginald Brown | Blackstone Group | 52 | |
| Denise Morrison | Visa Class A | 66 | |
| Das Narayandas | AllianceBernstein Holding LP | 60 | |
| Mark Pearson | AllianceBernstein Holding LP | 62 | |
| Maynard Webb | Visa Class A | 64 | |
| James Breyer | Blackstone Group | 59 | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0094 |
Morgan Stanley Leadership Team
Elected by the shareholders, the Morgan Stanley's board of directors comprises two types of representatives: Morgan Stanley inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morgan. The board's role is to monitor Morgan Stanley's management team and ensure that shareholders' interests are well served. Morgan Stanley's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morgan Stanley's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Glocer, Lead Independent Director | ||
| Simon Herrmann, Head Group | ||
| Sachin Wagle, CoHead India | ||
| James Gorman, Chairman of the Board, Chief Executive Officer | ||
| Takeshi Ogasawara, Director | ||
| Simon Evenson, Managing Director | ||
| Judith Miscik, Independent Director | ||
| Mary Schapiro, Independent Director | ||
| Shelley Leibowitz, Independent Director | ||
| Hironori Kamezawa, Director | ||
| Erika James, Independent Director | ||
| Michael Wilson, Chief Officer | ||
| Dennis Nally, Independent Director | ||
| Edward Pick, Head - Institutional Securities | ||
| Hutham Olayan, Independent Director | ||
| Stanislav Liberman, Managing Director | ||
| Eric Grossman, Chief Legal Officer, Executive Vice President | ||
| Rayford Wilkins, Independent Director | ||
| Jonathan Pruzan, Chief Financial Officer, Executive Vice President | ||
| Mandell Crawley, Chief Human Resource Officer | ||
| Marc Sgaraglino, Managing Director | ||
| Nobuyuki Hirano, Director | ||
| Sarah CFA, MD Centers | ||
| Andrew Saperstein, Head - Wealth Management | ||
| Robyn Goldschmid, Managing Director | ||
| Robert Herz, Independent Director | ||
| Robert Rooney, Head of Technology - Operations and Firm Resilience | ||
| James Boustead, Compliance Legal | ||
| Keishi Hotsuki, Executive Vice President, Chief Risk Officer | ||
| Perry Traquina, Independent Director | ||
| Alistair Darling, Independent Director | ||
| Jeffrey Brodsky, Chief Human Resource Officer, Executive Vice President | ||
| Elizabeth Corley, Independent Director | ||
| Michael Pizzi, Head Technology | ||
| Stephen Popovchak, Managing Director | ||
| Sharon Yeshaya, Chief Financial Officer | ||
| Raja Akram, Deputy Officer | ||
| Daniel Simkowitz, Head of Investment Management | ||
| Stephen Luczo, Independent Director | ||
| Clint Gartin, Chairman Banking |
Morgan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morgan Stanley a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0094 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 77.86 B | ||||
| Shares Outstanding | 1.61 B | ||||
| Shares Owned By Insiders | 23.67 % | ||||
| Shares Owned By Institutions | 62.18 % | ||||
| Number Of Shares Shorted | 14.76 M | ||||
| Price To Earning | 13.51 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Morgan Stock Analysis
When running Morgan Stanley's price analysis, check to measure Morgan Stanley's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Morgan Stanley is operating at the current time. Most of Morgan Stanley's value examination focuses on studying past and present price action to predict the probability of Morgan Stanley's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Morgan Stanley's price. Additionally, you may evaluate how the addition of Morgan Stanley to your portfolios can decrease your overall portfolio volatility.